Findings from the first clinical trial program comparing the use of Teva’s Digihaler® System to standard of care in asthma management will be presented across six abstractsTEL AVIV, Israel & PARSIPPANY, N.J. (BUSINESS WIRE) Teva Pharmaceuticals USA, Inc., a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NY.
The study evaluated the effect of the ProAir Digihaler System on asthma control versus standard of care as measured by the Asthma Control Test, and explored use of the ProAir Digihaler System to help